MedPath

Breastfeeding and Eating Nuts and Eggs For Infant Tolerance (BENEFIT) Trial

Not Applicable
Completed
Conditions
Inflammatory and Immune System - Allergies
Food Allergy
Registration Number
ACTRN12617001465347
Lead Sponsor
niversity of Western Australia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
109
Inclusion Criteria

Eligible participants will be women who are planning to breastfeed for at least 6 months. Infants to have at least two family members (mother, father or siblings) with medically diagnosed allergic disease (asthma, eczema, hay-fever or IgE mediated food allergy).

Exclusion Criteria

Women with egg or peanut allergies (<1% of adult population) will be excluded, as they would be unable to safely follow the intervention without an allergic reaction.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Egg-specific IgG4 concentrations in infant blood. These will be measured using the ImmunoCAP 250 system (Phadia AB, Uppsala, Sweden).[When Infant is 6 months of age.];Peanut-specific IgG4 concentrations in infant blood. These will be measured using the ImmunoCAP 250 system (Phadia AB, Uppsala, Sweden).[When infant is 6 months of age.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath